Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Papillomavirus Infections × Injections × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 61 Breast Neoplasms 47 Myelodysplastic Syndromes 25 Neoplasms 23 Advanced Solid Tumor 23 Carcinoma, Non-Small-Cell Lung 21 Advanced Solid Tumors 21 Prostatic Neoplasms 20 Stomach Neoplasms 18 Recurrence 17 Multiple Myeloma 16 Carcinoma, Hepatocellular 16 Neoplasm Metastasis 15 Leukemia, Myelomonocytic, Chronic 13 Solid Tumor 12 Pancreatic Neoplasms 12 Ovarian Neoplasms 12 Lung Neoplasms 12 Uterine Cervical Neoplasms 10 Melanoma 10 Lymphoma, Large B-Cell, Diffuse 10 Sarcoma 9 Triple Negative Breast Neoplasms 8 Small Cell Lung Carcinoma 8 Myeloproliferative Disorders 8 Colorectal Neoplasms 8 Lymphoma, B-Cell 7 Esophageal Neoplasms 7 Biliary Tract Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6

Interventions

human papillomavirus vaccine, L1 type 16, 18 34 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 27 Papillomavirus Vaccines 22 Vaccines 11 Human Papillomavirus Recombinant Vaccine nonavalent 10 Radiotherapy, Intensity-Modulated 7 Human Papillomavirus DNA Tests 7 Colposcopy 7 Cisplatin 7 Carboplatin 6 Vaccines, Synthetic 5 Specimen Handling 5 Educational Status 5 Blood Specimen Collection 5 Vaginal Smears 4 Engerix-B 4 Early Intervention, Educational 4 fludarabine 3 artesunic acid 3 artemisinin 3 Watchful Waiting 3 Surveys and Questionnaires 3 Paclitaxel 3 Methods 3 Imiquimod 3 Hepatitis A Vaccines 3 Cyclophosphamide 3 halofantrine 2 fludarabine phosphate 2 epigallocatechin gallate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04199689 2025-03-25

V503-049

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡